The Italian Competition Authority investigates the allegations of foreclosure of market access for a new generic drug for treating visual glaucoma (Pfizer)

Italian Competition Authority investigates Pfizer’s effort to obstruct market access for a new generic drug for treating visual glaucoma* On 13 October 2010, the Italian Competition Authority (“ICA”) opened an investigation to ascertain whether Pfizer’s attempt to prolong the patent protection for its active ingredient latanaprost constitutes an abuse of its dominant position in the market for products for treating visual glaucoma in

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Gabriele Accardo, The Italian Competition Authority investigates the allegations of foreclosure of market access for a new generic drug for treating visual glaucoma (Pfizer), 13 October 2010, e-Competitions Bulletin Competition in the Pharmaceutical sector, Art. N° 59631

Visites 103

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues